Clinical Trials on Childhood Favorable Prognosis Hodgkin Lymphoma
Total 5463 results
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Loyola UniversityCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Chinese PLA General HospitalShenzhen University General Hospital; Shenzhen UniversityUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang UniversityCompletedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-cell Non-Hodgkin LymphomaChina
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingB-cell Non-Hodgkin's LymphomaChina
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Ruijiamei Biotechnologies, Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
Hutchison Medipharma LimitedRecruiting
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech Pharmaceuticals Co.Ltd.Suspended
-
Sinocelltech Ltd.UnknownB-cell Non Hodgkin's LymphomaChina
-
Sinocelltech Ltd.Completed
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
Imugene LimitedRecruitingNon-Hodgkin Lymphoma | B-cell Acute Lymphoblastic LeukemiaUnited States
-
Shandong Provincial HospitalUnknownLymphoma, Non-Hodgkin;Hodgkin DiseaseChina
-
PfizerTerminatedHodgkins LymphomaUnited Kingdom, United States, Italy
-
University of CologneCompleted
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Molecular Templates, Inc.Terminated
-
Peking UniversityShanghai Mingju Biotechnology Co., Ltd.Unknown
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Zhao WeiliShanghai Mingju Biotechnology Co., Ltd.Unknown
-
Columbia UniversityMerck Sharp & Dohme LLCCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Cortice Biosciences, Inc.CompletedNeoplasms | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Tarapeutics Science Inc.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryChina
-
University of CologneCompletedNodular Lymphocyte-Predominant Hodgkin's LymphomaGermany
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Peking Union Medical College HospitalPeking University First Hospital; Chinese PLA General Hospital; Peking University... and other collaboratorsRecruitingT Cell Non-Hodgkin's LymphomaChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedLymphoma | Leukemia | Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | AML | Acute Myelogenous Leukemia | Hematologic Malignancy | Myeloma | Non-hodgkin's Lymphoma | CLL | ALLUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.WithdrawnChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic LymphomaUnited States
-
Shanghai Longyao Biotechnology Inc., Ltd.UnknownNon-Hodgkin Lymphoma | Relapsed and Refractory B Cell LymphomaChina
-
Genor Biopharma Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
Marco PicardiFederico II UniversityUnknownClassical Hodgkin Lymphoma | Diffuse Large B-cell-lymphomaItaly
-
Curon Biopharmaceutical (Shanghai) Co.,LtdRecruitingRelapsed or Refractory B-Cell Non-Hodgkin LymphomaChina
-
Cellular Biomedicine Group Ltd.Tianjin Medical University Cancer Institute and HospitalUnknownRefractory or Relapsed B-cell Non-Hodgkin LymphomaChina
-
Incyte CorporationTerminatedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin's Lymphoma